Literature DB >> 23558878

Acute myocardial infarction due to left main coronary artery disease: a large multicenter national registry.

Marcin Sadowski1, Wojciech Gutkowski, Agnieszka Janion-Sadowska, Mariusz Gąsior, Marek Gierlotka, Marianna Janion, Lech Poloński.   

Abstract

BACKGROUND: Optimal management of patients with acute myocardial infarction (MI) due to critical stenosis of an unprotected left main coronary artery (ULMCA) is not established. However, data from observational studies and registries encourage to perform percutaneous coronary intervention (PCI) in high risk patients. We investigated gender-related discrepancies, clinical course and prognosis in patients with acute MI and ULMCA as an infarct-related artery.
METHODS: A total of 643 consecutive patients (184 [28.6%] females and 459 [71.4%] males) with acute MI due to critical ULMCA stenosis were selected from the population of 121,526 patients hospitalized due to acute coronary syndromes between 2003 and 2006. The primary endpoints were in-hospital, 30-day, 6-month and 12-month mortality.
RESULTS: Women were older than men with significantly higher proportion of women older than 65 and with unfavorable risk profile. The management in men and women was similar. There was no significant gender-related differences in mortality in all follow-up periods. In multivariate analysis cardiogenic shock, pulmonary edema, ST elevation myocardial infarction (STEMI) and advanced age significantly increased mortality, whereas successful PCI decreased mortality.
CONCLUSIONS: No significant differences in clinical course, treatment and prognosis between men and women were noted. Mortality remained very high in both genders. The most unfavorable prognostic factors were cardiogenic shock, pulmonary edema, STEMI and advanced age. Percutaneous coronary angioplasty is feasible and offers high success rate in this subset of patients.

Entities:  

Mesh:

Year:  2013        PMID: 23558878     DOI: 10.5603/CJ.2013.0033

Source DB:  PubMed          Journal:  Cardiol J        ISSN: 1898-018X            Impact factor:   2.737


  5 in total

1.  Gender differences in patients with cardiogenic shock complicating myocardial infarction: a substudy of the IABP-SHOCK II-trial.

Authors:  Karl Fengler; Georg Fuernau; Steffen Desch; Ingo Eitel; Franz-Josef Neumann; Hans-Georg Olbrich; Antoinette de Waha; Suzanne de Waha; Gert Richardt; Marcus Hennersdorf; Klaus Empen; Rainer Hambrecht; Jörg Fuhrmann; Michael Böhm; Janine Poess; Ruth Strasser; Steffen Schneider; Gerhard Schuler; Karl Werdan; Uwe Zeymer; Holger Thiele
Journal:  Clin Res Cardiol       Date:  2014-10-07       Impact factor: 5.460

2.  Acute myocardial infarction due to left main coronary artery disease in men and women: does ST-segment elevation matter?

Authors:  Marcin Sadowski; Wojciech Gutkowski; Grzegorz Raczyński; Agnieszka Janion-Sadowska; Marek Gierlotka; Lech Poloński
Journal:  Arch Med Sci       Date:  2015-12-11       Impact factor: 3.318

3.  New Predictors of Early and Late Outcomes after Primary Percutaneous Coronary Intervention in Patients with ST-Segment Elevation Myocardial Infarction and Unprotected Left Main Coronary Artery Culprit Lesion.

Authors:  Cãlin Homorodean; Adrian Corneliu Iancu; Daniel Leucuţa; Şerban Bãlãnescu; Ioana Mihaela Dregoesc; Mihai Spînu; Mihai Ober; Dan Tãtaru; Maria Olinic; Dan Bindea; Dan Olinic
Journal:  J Interv Cardiol       Date:  2019-03-18       Impact factor: 2.279

Review 4.  Treatment strategies in the left main coronary artery disease associated with acute coronary syndromes.

Authors:  Ahmet Karabulut; Mahmut Cakmak
Journal:  J Saudi Heart Assoc       Date:  2015-03-21

5.  One-year Outcomes in Patients with ST-segment Elevation Myocardial Infarction Caused by Unprotected Left Main Coronary Artery Occlusion Treated by Primary Percutaneous Coronary Intervention.

Authors:  Hai-Wei Liu; Ya-Ling Han; Quan-Min Jin; Xiao-Zeng Wang; Ying-Yan Ma; Geng Wang; Bin Wang; Kai Xu; Yi Li; Shao-Liang Chen
Journal:  Chin Med J (Engl)       Date:  2018-06-20       Impact factor: 2.628

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.